<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01379417</url>
  </required_header>
  <id_info>
    <org_study_id>04.01.FR.INF</org_study_id>
    <secondary_id>2006-A00062-49</secondary_id>
    <nct_id>NCT01379417</nct_id>
  </id_info>
  <brief_title>Probiotics Supplementation in Premature Infants</brief_title>
  <official_title>Probiotics Supplementation and Nutritional Benefit in Premature Infants</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Nestlé</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Nestlé</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The main objective is to assess the nutritional benefit of probiotics supplementation on
      premature infants growth. As secondary objectives, different parameters related to probiotics
      tolerance will be measured.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>November 2007</start_date>
  <completion_date type="Actual">September 2010</completion_date>
  <primary_completion_date type="Actual">September 2010</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Weight (g)</measure>
    <time_frame>From 4 to 6 weeks after inclusion</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Growth</measure>
    <time_frame>between inclusion date and 4 to 6 weeks after inclusion (= end of supplementation period)</time_frame>
    <description>measured by:
weight gain (g/day)
height (cm/week)
head circumference(cm/week)</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">199</enrollment>
  <condition>Prematurity</condition>
  <arm_group>
    <arm_group_label>Maltodextrin</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Maltodextrin</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Probiotic B lactis/B longum</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Bifidobacterium lactis + Bifidobacterium longum</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Probiotic B longum</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Bifidobacterium longum</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Probiotic B lactis</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Bifidobacterium lactis</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Probiotic supplementation</intervention_name>
    <description>1 capsule per day, from inclusion to 4 or 6 weeks after inclusion</description>
    <arm_group_label>Maltodextrin</arm_group_label>
    <arm_group_label>Probiotic B lactis/B longum</arm_group_label>
    <arm_group_label>Probiotic B longum</arm_group_label>
    <arm_group_label>Probiotic B lactis</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion criteria

          -  Gestational age between 26 weeks and 31 weeks

          -  Birth weight between 700 to 1600 g

          -  Eutrophic infants (weight between -2 to 2 DS, Usher curves)

          -  Admitted to one of the participating hospital unit within the 8 days following the
             birth, the birth date equals the 1st day of life.

          -  Still on parenteral feeding or infusion on the 5th day of birth

        Non inclusion criteria

          -  Digestive disorders &gt; or equal to 1b on Bell stage

          -  Severe intra-ventricular haemorrhage (stage 3-4) before 5th day of life.

          -  Severe malformations or digestive malformations

          -  No antenatal corticosteroid therapy

          -  Severe medical or surgical disorder affecting the absorption, digesting and as a
             result the growth (Hirschsprung disease, lactose intolerance, cow milk protein
             allergy, mucoviscidosis).

          -  Parents geographical distance preventing the hospitalization follow-up in the hospital
             participating unit (geographical distance planned before the infant reaches 1500 g or
             32 weeks of gestational age)

        Exclusion criteria

          -  Enteral/Oral feeding termination during more than 72 hours due to severe digestive
             disorders (&gt; or equal to 2a on Bell stage )

          -  Serious digestive surgery
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>8 Days</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jean-Charles Picaud, Pr</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hôpital de la Croix-Rousse</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Service de Nénatologie, Hôpital Femme Mère Enfant</name>
      <address>
        <city>Bron</city>
        <zip>69678</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Service de Réanimation Néonatale et Néonatologie, Hôpital de la Croix Rousse</name>
      <address>
        <city>Lyon</city>
        <zip>69317</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Service de Réanimation Néonatale, Hôpital Arnaud de Villeneuve</name>
      <address>
        <city>Montpellier</city>
        <zip>34295</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>August 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 10, 2011</study_first_submitted>
  <study_first_submitted_qc>June 21, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 23, 2011</study_first_posted>
  <last_update_submitted>August 26, 2011</last_update_submitted>
  <last_update_submitted_qc>August 26, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 29, 2011</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Prematurity</keyword>
  <keyword>Nutrition</keyword>
  <keyword>Growth</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Premature Birth</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sulfalene</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

